Food Allergy: Symptoms, Causes, Treatment & Nursing Care

Food allergy is a reproducible adverse reaction to a specific food protein driven by the immune system, distinct from non-immune food intolerances such as lactose maldigestion or histamine sensitivity. The dominant mechanism is type I hypersensitivity, in which allergen-specific IgE bound to FcεRI receptors on mast cells and basophils cross-links on re-exposure, releasing histamine, tryptase, leukotrienes, prostaglandins, and platelet-activating factor. Within minutes those mediators act on cutaneous, mucosal, respiratory, gastrointestinal, and cardiovascular tissues to produce the patterns clinicians recognise as urticaria, angioedema, wheeze, vomiting, and—in the most extreme case—distributive shock.

A second, less familiar arm of food allergy is non-IgE-mediated and dominated by T-cell or eosinophil-driven inflammation: food protein-induced enterocolitis syndrome (FPIES), food protein-induced proctocolitis, eosinophilic oesophagitis (EoE) and gastroenteritis, and contact dermatitis to food handling. Mixed phenotypes also exist; atopic dermatitis can flare on exposure to a sensitising food without classic urticaria. The clinical implication is significant—blood IgE testing has limited value when the suspected mechanism is non-IgE, and management strategies diverge accordingly.

Food allergy is most prevalent in early childhood, declines for some triggers (milk, egg, wheat, soy) by school age, and is more often lifelong for peanut, tree nuts, fish, and shellfish. Adult-onset food allergy is well described—shellfish in adults, alpha-gal syndrome after tick exposure, pollen-food allergy syndrome cross-reacting with raw fruits and vegetables. Across age groups, the consequence that drives clinical urgency is anaphylaxis: food remains the leading single cause of anaphylactic deaths internationally.

Sorting reactions into IgE, non-IgE, and mixed phenotypes shapes investigation and treatment. The table below collapses the headline categories nurses meet on triage and clinic.

↔On a small screen, swipe or scroll sideways to see the full table.

Severity grading remains controversial; the World Allergy Organization, NIAID expert panel, and EAACI use overlapping but not identical schemes. Local protocols should drive documentation language so escalation pathways stay reproducible.

Most IgE food reactions begin within minutes and rarely beyond two hours of exposure. Clustering symptoms by organ system makes documentation and triage faster and matches how anaphylaxis criteria are written.

Typical IgE pattern

• Skin and mucosa: itching, flushing, urticarial wheals (hives), lip swelling, periorbital and tongue oedema, oral pruritus.
• Respiratory: nasal congestion, repeated sneezing, hoarse voice, chest tightness, wheezing, shortness of breath, stridor.
• Gastrointestinal: oral itch, cramping abdominal pain, nausea, projectile vomiting, sudden diarrhoea.
• Cardiovascular: presyncope, tachycardia disproportionate to anxiety, narrow pulse pressure, frank hypotension, loss of consciousness.
• Neurological / behavioural: dizziness, sense of impending doom, agitation, in young children sudden quiet limpness instead of crying.

Atypical and easily missed cues

• Sudden gastrointestinal symptoms with no urticaria can still represent anaphylaxis—particularly in children and with peanut, tree nut, or shellfish triggers.
• Oral allergy syndrome from raw apple, peach, hazelnut, or carrot in birch-allergic patients is usually mild but can rarely escalate—document the pattern and counsel.
• Repeated unexplained vomiting and pallor 1–4 hours after the same food in an infant should raise FPIES, not gastroenteritis.
• Adult-onset urticaria after red meat at evening meals points toward alpha-gal syndrome rather than typical IgE meat allergy.
• Persistent difficulty swallowing or food impaction in young adults can flag eosinophilic oesophagitis, a non-IgE mixed phenotype.

Why does the immune system react to a harmless food?

Predominant triggers worldwide

• Peanut—a leading cause of severe and fatal food anaphylaxis; cross-reactivity with tree nuts is variable.
• Tree nuts—cashew, walnut, hazelnut, almond, pistachio; co-sensitisation common but not universal.
• Cow’s milk—the most common allergy in infants; majority resolve by school age in IgE phenotypes.
• Hen’s egg—frequent in infancy; baked-egg tolerance often precedes raw-egg tolerance.
• Wheat—including exercise-induced wheat-dependent anaphylaxis; distinct from coeliac and from non-coeliac wheat sensitivity.
• Soy—significant in infancy; less common as severe trigger in adults.
• Fish and shellfish—often persistent; crustacean allergy is the dominant adult-onset pattern.
• Sesame—now formally labelled as a major allergen in many jurisdictions; cross-contamination is a recurring counselling point.

Modifiable and contextual risk factors

• Severe atopic eczema in infancy—the single strongest risk modifier for early peanut allergy.
• Delayed introduction of peanut and egg in high-risk infants, contrary to current guidance.
• Poorly controlled asthma at the time of reaction.
• Concomitant cofactors (exercise, NSAIDs, alcohol, viral illness) lowering the eliciting dose.
• Use of acid suppression in infancy (still debated; mechanism via altered protein digestion).

Non-modifiable contributors

• Family history of atopy in first-degree relatives.
• Filaggrin loss-of-function and other skin-barrier genetic variants.
• Coexistent allergic disease—rhinitis, asthma, atopic dermatitis—indicates a Th2-skewed background.

Food allergy is diagnosed clinically. Tests support a hypothesis built from the history; they do not establish allergy on their own. The order of operations follows NICE and NIAID frameworks—history first, targeted testing second, supervised challenge if uncertainty remains.

Allergy-focused clinical history

• Exact food, form (raw, cooked, processed), and quantity ingested; co-eaten foods.
• Time from ingestion to first symptom and time to peak.
• Organ systems involved and severity (need for adrenaline, hospital, ITU).
• Reproducibility on prior exposures.
• Cofactors at the time—exercise, NSAIDs, alcohol, intercurrent illness, menstruation.
• Atopic background—eczema, asthma, allergic rhinitis—and growth in children.
• Family history of food allergy or atopy.
• Current treatments and any β-blocker or ACE inhibitor use that could complicate management.

First-line laboratory and bedside testing

• Skin prick test (SPT): rapid, sensitive, performed in a clinic prepared for anaphylaxis; preferred where available for IgE-mediated suspicion. Stop antihistamines for the recommended washout window.
• Specific IgE blood test (sIgE / ImmunoCAP): useful when SPT is impractical (extensive eczema, dermatographism, antihistamine cannot be stopped, infants); always interpreted alongside the history rather than in isolation.
• Component-resolved diagnostics: specialist tools (e.g. Ara h 2 for peanut) refine risk stratification when whole-extract testing is equivocal.
• Tryptase (acute and baseline): rises in some anaphylactic reactions but may be normal in food-induced events; never delays adrenaline.
• General bloods: a complete blood count and serum immunoglobulins have a limited role outside specialist workup but are sometimes requested when a non-IgE phenotype is being mapped.

Specialist-only investigations

• Oral food challenge: the diagnostic reference standard; performed in a centre with full anaphylaxis capability—never as a primary-care decision.
• Endoscopy with mucosal biopsy: for eosinophilic oesophagitis and eosinophilic gastroenteritis when symptoms warrant.
• Atopy patch testing: not recommended in primary care for IgE food allergy and not a reliable single test for non-IgE allergy in most settings.

Tests to avoid

• Serum-specific IgG or IgG4 to foods (no proven diagnostic role; promotes unnecessary avoidance).
• Hair analysis, applied kinesiology, vega testing (no evidence base; not offered).
• Empirical multi-food elimination without dietitian supervision in children (nutritional risk).

Vital-sign reassessment thresholds during evaluation

↔On a small screen, swipe or scroll sideways to see the full table.

Once a food trigger is suspected, decisions sit in three layers: severity now, mechanism likely (IgE vs non-IgE), and where the patient should be reviewed next.

1. Stabilise first: If multisystem symptoms after a likely food, give intramuscular adrenaline, position safely, oxygen, IV access. Do not pause to draw bloods if the diagnosis is clinical.
2. Phenotype the reaction: Immediate (<2 h) urticaria/angioedema/wheeze → IgE pattern. Delayed (1–4 h) repetitive vomiting/pallor/lethargy → think FPIES. Chronic loose stool with mucus or blood in an infant → proctocolitis. Adult dysphagia → consider EoE.
3. Confirm trigger: Allergy-focused history, then SPT or sIgE for IgE patterns; supervised elimination–reintroduction with dietitian for non-IgE; oral food challenge under specialist care if uncertainty remains.
4. Set the safety-net: For confirmed IgE allergy, supply two adrenaline autoinjectors, written action plan, and arrange specialist follow-up; for non-IgE in children, dietitian review for nutritional adequacy.
5. Reassess co-conditions: Optimise asthma control, eczema therapy, and review medications—β-blockers, ACE inhibitors, NSAIDs change the risk landscape.
6. Refer or escalate for: anaphylaxis, multiple suspected foods, faltering growth, severe atopic dermatitis with suspected food trigger, ambiguous testing, or consideration of montelukast or biologic adjuncts under specialist supervision.

Several non-allergic reactions to food (and a handful of unrelated conditions) mimic the picture nurses are asked to triage as “food allergy”. Distinguishing them prevents both over- and under-treatment.

↔On a small screen, swipe or scroll sideways to see the full table.

Therapy targets two phases: acute reaction (anaphylaxis-first) and long-term avoidance with structured emergency planning. Match aggressiveness to severity, age, asthma status, and trigger pattern.

Acute reaction—first-line

• Intramuscular adrenaline (epinephrine), mid-outer thigh: 0.01 mg/kg of 1 mg/mL preparation (max 0.3 mg child, 0.5 mg adult). Repeat at 5–15 minutes if no improvement.
• Position: supine with legs elevated unless airway compromise demands sitting up; do not stand or walk a hypotensive patient.
• High-flow oxygen via non-rebreather; secure airway readiness.
• IV access × 2: isotonic crystalloid bolus (10–20 mL/kg, repeated as ordered) for hypotension.
• Bronchospasm: nebulised albuterol as adjunct—does not replace adrenaline.

Acute reaction—adjuncts (after first-line, not instead)

• H1 antihistamines: oral or parenteral cetirizine, loratadine, or where parenteral access matters and sedation is acceptable, diphenhydramine—useful for cutaneous symptoms only.
• Systemic corticosteroids: hydrocortisone IV or oral prednisone—evidence for biphasic prevention is limited; current resuscitation guidance has moved away from routine steroid use, but practice still varies.
• Refractory shock: escalate to critical care; vasopressors per protocol; methylprednisolone may be ordered when severe asthma overlap is dominant.

Long-term management

• Strict trigger avoidance with allergen-aware label reading, restaurant communication, and (for paediatric cases) school plans.
• Two in-date adrenaline autoinjectors carried at all times; replace before expiry.
• Personalised written emergency action plan reviewed annually.
• Asthma optimisation with inhaled corticosteroid + reliever therapy; uncontrolled asthma is the dominant amplifier of fatal food anaphylaxis.
• Dietitian input for paediatric multi-allergy avoidance, infant cow’s-milk-protein allergy, and any non-IgE elimination diet.
• Vaccination: standard schedules apply; egg-allergic patients can receive most current influenza and MMR vaccines per national guidance—check local protocols.

Specialist-directed therapy

• Oral immunotherapy (OIT)—available for peanut and increasingly for milk and egg in selected centres; supervised escalation and maintenance phases with on-the-day adrenaline readiness.
• Omalizumab—FDA-approved (2024) to reduce risk of severe allergic reactions to accidental exposure to one or more foods in patients ≥1 year, used adjunctively to continued avoidance.
• Sublingual immunotherapy protocols in selected food allergens under research and selective use.

Special populations

• Infants and young children: weight-based adrenaline; teach caregivers and any school nurse on device-specific technique.
• Pregnancy: untreated anaphylaxis poses greater fetal risk than appropriately dosed adrenaline; arrange obstetric monitoring after stabilisation.
• Older adults and those on β-blockers / ACE inhibitors: blunted compensatory responses—lower threshold to escalate; glucagon may be considered for refractory β-blocker-related hypotension per local algorithms.
• Renal or hepatic impairment: sedating antihistamines accumulate; choose second-generation oral agents and review with pharmacy.

• Monitoring cadence after adrenaline: vital signs every 5–15 min until stable; SpO₂ continuously when respiratory involvement; hourly thereafter through the observation window. Pulse oximetry trends often shift before subjective symptoms recur.
• Observation length: at least 4–6 hours for moderate–severe reactions; longer when a second adrenaline dose was needed, asthma is poorly controlled, or the reaction was protracted; document the local pathway used.
• Treatment failure: persistent hypotension or wheeze after two appropriate adrenaline doses mandates critical-care escalation, infusion pressors, and senior airway review.
• Referral urgency: same-week allergy and immunology for any new systemic reaction, anaphylaxis, multiple suspected triggers, faltering growth in children, severe eczema with suspected food link, or planning of OIT or biologic therapy.
• Documentation: exact food, ingredient list where possible, time to symptom, organs involved, treatments given (route, dose, time), response, and education provided. Update problem lists and allergy fields immediately—free-text “food allergy” without specifics blocks safe care later.
• MDT roles: dietitian for paediatric and complex avoidance, pharmacist for autoinjector prescription and counselling, school nurse or occupational health for action-plan integration, asthma team for control optimisation.

Bedside monitoring checklist

• Continuous SpO₂ if any airway involvement.
• Two large-bore IVs when fluid resuscitation or pressor escalation is plausible.
• Repeat blood pressure on the unaffected limb to avoid spurious readings.
• Glucose check in children after adrenaline (tremor mimics hypoglycaemia).
• Reassess airway sounds for late stridor before considering discharge.

• Death from untreated or under-treated anaphylaxis—most often associated with delayed adrenaline, asthma, and adolescence/young adulthood.
• Hypoxic brain injury after prolonged shock or airway obstruction.
• Aspiration during reduced consciousness—position carefully and have suction ready.
• Faltering growth and micronutrient deficiency in children on poorly supervised multi-food avoidance.
• Anxiety, food avoidance disorders, and reduced quality of life—particularly in adolescents and parents of young children.
• Recurrent oesophageal food impaction in untreated eosinophilic oesophagitis.

Primary prevention is most evidence-based for peanut allergy in high-risk infants. The 2017 NIAID addendum, built on the LEAP trial, recommends early introduction of peanut-containing foods between 4 and 6 months in infants with severe eczema or egg allergy after specialist evaluation; mild-to-moderate eczema warrants introduction around 6 months; infants with no eczema or food allergy follow normal weaning. Early introduction has reduced peanut allergy incidence by roughly 80% in high-risk cohorts when applied correctly.

Beyond infancy, prevention shifts to averting reactions in established allergy: optimising asthma control, vigilant label reading, cross-contamination awareness in food preparation, school and workplace action plans, and prompt adrenaline use. Vaccination uptake matters indirectly—respiratory infections destabilise asthma and lower the threshold for severe reactions during accidental exposure.

Outcomes depend on trigger and phenotype. Cow’s milk, egg, wheat, and soy IgE allergies in childhood frequently resolve by adolescence under specialist follow-up; baked-egg or baked-milk tolerance often precedes full tolerance and supports stepwise reintroduction protocols. Peanut, tree nut, fish, and shellfish allergies tend to persist into adulthood, with peanut resolution rates around 20% in childhood-onset cases.

FPIES generally resolves by 3–5 years of age for most triggers, though seafood-induced FPIES in adults can persist. Non-IgE eosinophilic disease such as EoE is chronic and relapsing, requiring long-term management. Prognosis after anaphylaxis hinges on trigger avoidance literacy, autoinjector access, and asthma control—dual food allergy plus poorly controlled asthma is the highest-risk combination and the one teams should flag prominently in handovers.

Medication safety

Verify the adrenaline ampoule strength before drawing—1 mg/mL versus 0.1 mg/mL paediatric dilutions cause sound-alike errors under stress. Chart whether antihistamines given were sedating to inform safe observation. Re-check the autoinjector expiry at every encounter; expired devices fail when needed.

Communication

Use teach-back for autoinjector technique and action-plan triggers in the patient’s preferred language. Photograph rashes with consent for outpatient allergy review. For paediatric patients, ensure schools, after-school clubs, and grandparents have a copy of the action plan and a trainer pen.

Assessment essentials

A focused head-to-toe assessment after a reaction catches angioedema in less obvious areas (uvula, soft palate, perianal swelling), perfusion status, and respiratory effort. Edema mapping—facial, peri-orbital, lingual—helps trend airway risk during the observation window.

Escalation triggers

• Stridor, inability to complete sentences, or silent chest after presumed treatment.
• Systolic blood pressure falling despite fluids and repeated adrenaline.
• New altered consciousness or repeated vomiting in a child after recovery.
• Recurrent symptoms during observation window suggesting biphasic reaction.
• Persistent hypoxia despite oxygen and bronchodilator.

While organising transfer, give intramuscular adrenaline at the first sign of multisystem involvement, position safely, deliver oxygen, secure IV access, and document precise medication times so the receiving team can plan ongoing care without guesswork.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of food-allergy recognition (IgE-mediated anaphylaxis vs non-IgE / FPIES / oral-allergy / coeliac), structured anaphylaxis care, specific-IgE / skin-prick testing, oral-food challenge and early-allergen-introduction (LEAP) advice with the biphasic-anaphylaxis / fluid-refractory shock red flags.